Planning Capital Management Corporation’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$996	Hold	1,100	–	–	﹤0.01%	630
2024 Q2	$1.1K	Buy	1,100 +1,000	+1,000%	+$998	﹤0.01%	581
2024 Q1	$148	Hold	100	–	–	﹤0.01%	647
2023 Q4	$109	Buy	+100	New	+$109	﹤0.01%	641